2.
组间和组内疗效比较
Comparison of therapeutic efficacy between and within the two groups
| Outcome indicators | Medication node | Group | P | ||
| Test | Control | ||||
| White blood cell count (109/L) | |||||
| Before | 12.53 (6.83, 18.81) 32.26% |
10.19(7.05, 15.21) 37.10% |
0.292 | ||
| After | 7.77 (5.70, 11.20) 64.52% |
7.61 (5.30, 12.11) 43.55% |
0.901 | ||
| P | 0.003 | 0.039 | |||
| Neutrophil (%) | |||||
| Before | 82.75 (69.10, 90.28) 29.03% |
77.35 (60.15, 84.88) 33.87% |
0.024 | ||
| After | 66.29±16.03 62.90% |
70.05 (56.08, 81.05) 43.55% |
0.642 | ||
| P | 0.00 | 0.139 | |||
| C-reactive protein (mg/r) | |||||
| Before | 77.84 (7.80, 90.00) 29.03% |
28.51 (5.64, 74.75) 29.03% |
0.069 | ||
| After | 24.30 (5.50, 79.00) 37.10% |
20.10(3.50, 65.10) 40.23% |
0.310 | ||
| P | 0.098 | 0.385 | |||
| Procalcitonin（ng/mL） | |||||
| Before | 1.02 (0.19, 5.68) 20.97% |
1.10(0.15, 6.16) 29.03% |
0.851 | ||
| After | 0.11 (0.050.14) 82.26% |
0.28(20, 4.18) 43.55% |
0.00 | ||
| P | 0.00 | 0.072 | |||